Pediatric-onset Multiple Sclerosis in Families: A Distinct Phenotype

Objective: Multiple sclerosis (MS) is a chronic, immune-mediated disease of the central nervous system.Pediatric-onset MS (POMS) represents a distinct subgroup with unique clinical and immunological features.Although familial predisposition contributes to MS pathogenesis, data on familial POMS remain limited.To investigate the demographic and clinical characteristics of familial POMS and compare them with those of the broader MS patient cohort. Materials and Methods:We performed a retrospective descriptive analysis of 3,411 patients diagnosed with MS at a university hospital MS center.Of these, 523 had a family history of MS, and 251 were identified as having POMS, defined as disease onset before age 18.Data on demographic and clinical characteristics, cerebrospinal fluid (CSF) findings, treatment history, and disability scores were analyzed using IBM SPSS version 25.Results: Among 3,411 MS patients, 251 (7.36%) had POMS.Of these, 177 (70.5%) were female and 74 (29.5%) were male.Most had a relapsingremitting course (236 patients, 94%), while 15 (6%) developed secondary progressive MS; no cases of primary progressive MS were identified.Within the 523 familial MS cases, 51 (9.75%) had POMS.CSF analysis was available for 31 patients, 24 (77.4%) of whom showed MS-specific abnormalities; 13 (41.9%)had an elevated IgG index.Regarding treatment history, 59 patients (23.5%) received first-line therapies, 123 (49%) second-line therapies, and 69 (27.5%) third-line therapies.The mean Expanded Disability Status Scale score was 1.3. Conclusion:This study adds to the literature on POMS by providing detailed demographic, clinical, and familial data.The findings underscore the importance of considering familial predisposition when evaluating pediatric MS and highlight the need for further research into the genetic and immunological mechanisms underlying POMS.Long-term follow-up and genetic studies are warranted to deepen understanding of this uncommon yet clinically important MS subtype.

Authors

Publication Details

Journal
Journal of Multiple Sclerosis Research
Published
2025-08-29
DOI
https://doi.org/10.4274/jmsr.galenos.2025.2025-4-1
Primary Topic
Genomic variations and chromosomal abnormalities
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pediatric-onset Multiple Sclerosis in Families: A Distinct Phenotype

Yasemin Şimşek, Can Çalışkan, Ela Simay Zengin, Said Alizada
Journal of Multiple Sclerosis Research
Genomic variations and chromosomal abnormalities
article

Pediatric-onset Multiple Sclerosis in Families: A Distinct Phenotype

Yasemin Şimşek, Can Çalışkan, Ela Simay Zengin, Said Alizada
article en

Abstract

Objective: Multiple sclerosis (MS) is a chronic, immune-mediated disease of the central nervous system.Pediatric-onset MS (POMS) represents a distinct subgroup with unique clinical and immunological features.Although familial predisposition contributes to MS pathogenesis, data on familial POMS remain limited.To investigate the demographic and clinical characteristics of familial POMS and compare them with those of the broader MS patient cohort. Materials and Methods:We performed a retrospective descriptive analysis of 3,411 patients diagnosed with MS at a university hospital MS center.Of these, 523 had a family history of MS, and 251 were identified as having POMS, defined as disease onset before age 18.Data on demographic and clinical characteristics, cerebrospinal fluid (CSF) findings, treatment history, and disability scores were analyzed using IBM SPSS version 25.Results: Among 3,411 MS patients, 251 (7.36%) had POMS.Of these, 177 (70.5%) were female and 74 (29.5%) were male.Most had a relapsingremitting course (236 patients, 94%), while 15 (6%) developed secondary progressive MS; no cases of primary progressive MS were identified.Within the 523 familial MS cases, 51 (9.75%) had POMS.CSF analysis was available for 31 patients, 24 (77.4%) of whom showed MS-specific abnormalities; 13 (41.9%)had an elevated IgG index.Regarding treatment history, 59 patients (23.5%) received first-line therapies, 123 (49%) second-line therapies, and 69 (27.5%) third-line therapies.The mean Expanded Disability Status Scale score was 1.3. Conclusion:This study adds to the literature on POMS by providing detailed demographic, clinical, and familial data.The findings underscore the importance of considering familial predisposition when evaluating pediatric MS and highlight the need for further research into the genetic and immunological mechanisms underlying POMS.Long-term follow-up and genetic studies are warranted to deepen understanding of this uncommon yet clinically important MS subtype.

Journal of Multiple Sclerosis Research
Openalex Percentile: Top 75%
Genomic variations and chromosomal abnormalities
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pediatric-onset Multiple Sclerosis in Families: A Distinct Phenotype — Yasemin Şimşek, Can Çalışkan, et al. · Journal of Multiple Sclerosis Research (2025) | TGRS Research Map | TGRS